IE39113L - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE39113L
IE39113L IE740703A IE70374A IE39113L IE 39113 L IE39113 L IE 39113L IE 740703 A IE740703 A IE 740703A IE 70374 A IE70374 A IE 70374A IE 39113 L IE39113 L IE 39113L
Authority
IE
Ireland
Prior art keywords
active agent
water
wax
surface active
solvent
Prior art date
Application number
IE740703A
Other versions
IE39113B1 (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE39113L publication Critical patent/IE39113L/en
Publication of IE39113B1 publication Critical patent/IE39113B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1478009 Pharmaceutical compositions GLAXO LABORATORIES Ltd 11 June 1974 [2 April 1973] 15758/73 Heading A5B Substantially oil-free pharmaceutical creams comprise (a) a topically active anti-inflammatory steroid/except 21-chloro-9α-fluoro-#<SP>4</SP>- pregnene-11#, 16α, 17α-triol-3, 20-dione-16, 17-acetonide) in (b) a vehicle comprising a dispersion of a hydrophobic wax in an aqueous phase comprising water, a surface active agent, and a water-miscible hydroxylic solvent, the wax, water, solvent and surface active agent being present in amounts of 5 to 30%, 7 to 75%, 10 to 80% and 0.1 to 10% respectively, based on the weight of the composition. The steroid may be corticosteroid. The hydroxylic solvent may be a propanediol, a dipropylene glycol, a liquid polyethylene glycol or glycerol. The wax may be a waxy triglyceride, a waxy fatty alcohol, a saturated fatty acid, an acetoglyceride or beeswax. The surface active agent may be a polyoxyethylene ether or ester, sodium lauryl sulphate or sodium dioctyl sulphosuccinate. The compositions may contain other drugs such as antibodies, local anaesthetics, bactericides or antifungal compounds. [GB1478009A]
IE00703/74A 1973-04-02 1974-04-01 Pharmaceutical compositions IE39113B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1575873A GB1478009A (en) 1973-04-02 1973-04-02 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IE39113L true IE39113L (en) 1974-10-02
IE39113B1 IE39113B1 (en) 1978-08-02

Family

ID=10064952

Family Applications (1)

Application Number Title Priority Date Filing Date
IE00703/74A IE39113B1 (en) 1973-04-02 1974-04-01 Pharmaceutical compositions

Country Status (11)

Country Link
JP (1) JPS589081B2 (en)
BE (1) BE813153A (en)
CA (1) CA1045974A (en)
DE (1) DE2347243A1 (en)
DK (1) DK144358C (en)
FR (1) FR2222998B1 (en)
GB (1) GB1478009A (en)
IE (1) IE39113B1 (en)
LU (1) LU69751A1 (en)
NL (1) NL7404378A (en)
ZA (1) ZA742064B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (en) * 1980-06-19 1981-12-20 Draco Ab PHARMACEUTICAL PREPARATION
KR830005852A (en) * 1980-07-18 1983-09-14 미첼 페터 잭슨 Preparation of topical treatments suitable for the treatment of viral infections on skin and mucous membranes
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
DE3225848A1 (en) * 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen PREPARATION OF CORTICOIDS FOR TOPICAL APPLICATION
US4868169A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steroid cream formulation
LU87457A1 (en) * 1989-02-24 1990-09-19 Oreal USE, AS A COSMETIC COMPOSITION FOR HAIR, OF A WAX MICRODISPERSION, AND METHOD FOR TREATING HAIR WITH SUCH A COMPOSITION
US8491875B2 (en) * 2010-08-18 2013-07-23 Kao Corporation Hair volumizing compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB765600A (en) * 1954-01-15 1957-01-09 Drug Houses Of Australia Ltd Salves for veterinary use
GB903407A (en) * 1958-07-25 1962-08-15 Upjohn Co Improvements in or relating to antibacterial antiperspirant compositions
DE1198011B (en) * 1962-08-04 1965-08-05 Iwao Kawakami Skin care products
BR6789910D0 (en) * 1966-10-17 1973-05-17 Fmc Corp PROCESS TO PREPARE EDIBLE CONTAINING MICRO CRYSTALLINE COLLAGEN

Also Published As

Publication number Publication date
AU6724674A (en) 1975-10-02
NL7404378A (en) 1974-10-04
FR2222998B1 (en) 1977-11-04
JPS589081B2 (en) 1983-02-18
CA1045974A (en) 1979-01-09
LU69751A1 (en) 1974-07-17
BE813153A (en) 1974-10-01
IE39113B1 (en) 1978-08-02
FR2222998A1 (en) 1974-10-25
ZA742064B (en) 1975-03-26
DK144358B (en) 1982-03-01
JPS5058218A (en) 1975-05-21
DK144358C (en) 1984-04-09
GB1478009A (en) 1977-06-29
DE2347243A1 (en) 1974-10-10

Similar Documents

Publication Publication Date Title
US4363806A (en) Pharmaceutical composition
US4305936A (en) Topical corticosteroid formulations
US4083974A (en) Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
US4185100A (en) Topical anti-inflammatory drug therapy
US4052513A (en) Stable topical anesthetic compositions
CA1041011A (en) Anhydrous candicidin foam compositions
GB1450507A (en) Stabilized tretinoin cream emulsion
KR840006440A (en) Preparation method of topical external pharmaceutical composition
US3210248A (en) Emollient gel comprising lanolin alcohol, microcrystalline wax and a liqquid fatty acid ester
JPS6323971B2 (en)
US4048310A (en) Topical steroid formulation in form of lotion or cream
CA1139665A (en) Corticosteroid formulations containing sebacate carrier
PT93638A (en) A process for the preparation of a composition for the topical application of vitamin A
US6495602B1 (en) Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs
JPH0729929B2 (en) Cream containing hydrocortisone diester
CA1182048A (en) Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
IE39113L (en) Pharmaceutical compositions
KR840005020A (en) Corticosteroid external preparations
IE35203B1 (en) Steroid-containing pharmaceutical preparations
US4473565A (en) Topical anti-inflammatory drug therapy
AU698847B2 (en) Topical composition containing penciclovir
GB2084465A (en) Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
US3624221A (en) Method of distributing the sebaceous secretions of the skin
US3342676A (en) Dermatological composition containing 21-desoxy-9-alpha-fluoro-6-methyl prednisolone
IE36705L (en) Anaesthetic composition containing pregnane derivatives